ARIPIPRAZOLE

Product NDC
70518-3011
11-digit product format
705183011
Labeler code
70518
Product ID
70518-3011_ba711a43-c0b2-9415-e053-2a95a90a6e26
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ARIPIPRAZOLE
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA206251
Marketing category
ANDA
Marketing start
2021-02-02
Marketing end
0000-00-00
Substance
ARIPIPRAZOLE
Active strength
20 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3011-02023-03-14C16284748780-1f386c649-a588-0266-e053-dadaa90a7c1a78655692-0416-480d-a940-8c27293b9fe4
70518-3011-02023-01-30C16284748780-1f386c649-a588-0266-e053-dadaa90a7c1a78655692-0416-480d-a940-8c27293b9fe4

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3011-070518301100100 POUCH in 1 BOX (70518-3011-0) > 1 TABLET in 1 POUCH (70518-3011-1) 100 pouch2021-02-020000-00-00NoNoCurrent